| Primary |
| Multiple Myeloma |
42.1% |
| Acute Lymphocytic Leukaemia |
14.2% |
| Prophylaxis |
5.0% |
| Prostate Cancer |
3.8% |
| Glioblastoma Multiforme |
3.7% |
| Non-small Cell Lung Cancer |
3.6% |
| Prophylaxis Of Nausea And Vomiting |
3.1% |
| Chemotherapy |
2.9% |
| Breast Cancer |
2.6% |
| Pain |
2.6% |
| Hypertension |
2.2% |
| Product Used For Unknown Indication |
2.1% |
| Hodgkin's Disease |
1.7% |
| Diabetes Mellitus |
1.6% |
| Mantle Cell Lymphoma |
1.6% |
| Asthma |
1.4% |
| Langerhans' Cell Granulomatosis |
1.4% |
| Nausea |
1.4% |
| Premedication |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
|
| Pulmonary Embolism |
9.6% |
| Drug Ineffective |
9.1% |
| Pneumonia |
7.4% |
| Vomiting |
7.4% |
| Pneumocystis Jiroveci Pneumonia |
7.1% |
| White Blood Cell Count Decreased |
5.6% |
| Psychotic Disorder |
5.3% |
| Drug Exposure During Pregnancy |
5.1% |
| Weight Decreased |
5.1% |
| Sepsis |
4.6% |
| Thrombocytopenia |
4.3% |
| Renal Failure |
3.8% |
| Diabetic Ketoacidosis |
3.6% |
| Hyperglycaemia |
3.6% |
| Premature Baby |
3.3% |
| Multiple Myeloma |
3.0% |
| Pyrexia |
3.0% |
| Renal Failure Acute |
3.0% |
| Reversible Posterior Leukoencephalopathy Syndrome |
3.0% |
| Small For Dates Baby |
3.0% |
|
| Secondary |
| Multiple Myeloma |
23.9% |
| Product Used For Unknown Indication |
19.3% |
| Drug Use For Unknown Indication |
12.4% |
| Prophylaxis |
7.8% |
| Premedication |
4.6% |
| Hypertension |
3.9% |
| Prophylaxis Of Nausea And Vomiting |
3.4% |
| Breast Cancer |
3.2% |
| Constipation |
2.9% |
| Pain |
2.7% |
| Acute Lymphocytic Leukaemia |
2.5% |
| Glioblastoma Multiforme |
2.1% |
| Chemotherapy |
1.9% |
| Asthma |
1.9% |
| Insomnia |
1.4% |
| Neoplasm Malignant |
1.4% |
| Non-hodgkin's Lymphoma |
1.4% |
| Pyrexia |
1.2% |
| Nausea |
1.2% |
| Plasma Cell Myeloma |
1.0% |
|
| White Blood Cell Count Decreased |
13.2% |
| Weight Decreased |
8.7% |
| Vomiting |
7.8% |
| Hepatitis |
7.6% |
| Pyrexia |
7.5% |
| Pneumocystis Jiroveci Pneumonia |
6.7% |
| Pulmonary Embolism |
5.6% |
| Somnolence |
4.3% |
| Thrombocytopenia |
4.3% |
| White Blood Cell Count Increased |
4.2% |
| Weight Increased |
3.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.3% |
| Pneumonia |
3.3% |
| Drug Exposure During Pregnancy |
3.0% |
| Dyspnoea |
3.0% |
| Respiratory Failure |
3.0% |
| Urinary Tract Infection |
3.0% |
| Nausea |
2.8% |
| Pneumonia Aspiration |
2.6% |
| Rash |
2.6% |
|
| Concomitant |
| Prophylaxis |
17.2% |
| Drug Use For Unknown Indication |
16.0% |
| Multiple Myeloma |
10.8% |
| Product Used For Unknown Indication |
8.9% |
| Premedication |
7.7% |
| Pain |
3.8% |
| Breast Cancer |
3.8% |
| Non-small Cell Lung Cancer |
3.8% |
| Hypertension |
3.5% |
| Nausea |
2.9% |
| Constipation |
2.9% |
| Colorectal Cancer |
2.8% |
| Prophylaxis Of Nausea And Vomiting |
2.6% |
| Colon Cancer |
2.4% |
| Cancer Pain |
2.2% |
| Glioblastoma Multiforme |
2.0% |
| Metastases To Bone |
1.9% |
| Insomnia |
1.7% |
| Breast Cancer Metastatic |
1.7% |
| Rectal Cancer |
1.6% |
|
| Vomiting |
14.0% |
| White Blood Cell Count Decreased |
13.4% |
| Weight Decreased |
9.0% |
| Interstitial Lung Disease |
7.8% |
| Pneumonia |
5.2% |
| Pyrexia |
5.0% |
| Death |
4.7% |
| Thrombocytopenia |
4.7% |
| Pulmonary Embolism |
4.6% |
| Sepsis |
4.1% |
| Platelet Count Decreased |
4.0% |
| Neutropenia |
3.3% |
| Rash |
3.1% |
| Tooth Extraction |
2.9% |
| Stomatitis |
2.5% |
| Nausea |
2.5% |
| Renal Failure Acute |
2.5% |
| Neuropathy Peripheral |
2.3% |
| White Blood Cell Count Increased |
2.2% |
| Vision Blurred |
2.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
72.9% |
| Acute Lymphocytic Leukaemia |
22.2% |
| Antifungal Prophylaxis |
2.1% |
| Prophylaxis Of Nausea And Vomiting |
2.1% |
| Cushing's Syndrome |
0.7% |
|
| Pyrexia |
50.0% |
| Drug Interaction |
20.0% |
| Infusion Site Extravasation |
10.0% |
| Infusion Site Phlebitis |
10.0% |
| Middle Insomnia |
10.0% |
|
